Diabetes and Cancer

Diabetes and malignant growth are predominant ailments with high effect on wellbeing around the world. Epidemiologic observer proposes that individuals with diabetes are at altogether higher hazard for some types of malignancy. Type 2 diabetes and malignancy share a few hazard factors, however conceivable biologic connections between the two infections are not entirely comprehended. Besides, observer from observational investigations recommends that a few meds used to treat hyperglycemia are connected with either expanded or decreased danger of malignant growth.

 

    Related Conference of Diabetes and Cancer

    February 24-25, 2025

    34th European Diabetes Congress

    London, UK
    March 10-11, 2025

    4th Global Summit on Physiology and Metabolism of Thyroid

    Singapore City, Singapore
    March 17-18, 2025

    5th European Endocrinology and Diabetes Congress

    Paris, France
    April 10-11, 2025

    4th International Summit on Hormonal Disorders

    Dubai, UAE
    April 10-11, 2025

    5th World Congress on Endocrine and Diabetes

    Dubai, UAE
    May 19-20, 2025

    6th World Summit on Diabetes

    Rome, Italy
    June 04-05, 2025

    4th World Congress on Diabetes and Pediatric Endocrinology

    Edinburgh, Scotland
    July 29-30, 2025

    15th World Congress on Endocrinology and Diabetes

    Aix-en-Provence, France
    September 08-09, 2025

    3rd World congress and Expo on Diabetes

    Frankfurt, Germany
    October 30-31, 2025

    5th Annual Summit on Diabetes and Endocrinology

    Paris, France
    November 06-07, 2025

    8th Annual Meeting on Diabetes and Endocrinology

    Dubai, UAE
    November 20-21, 2025

    21st World Congress on Endocrinology & Diabetes

    Paris, France

    Diabetes and Cancer Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in